Overview Financials News + Filings Key Docs Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Spine and Dental | 90.9 | | | |
| Other countries | 279.3 | 333.3 | 281.2 | |
| U.S. | 630.1 | 675.6 | 615.7 | 697.6 |
| Other | | | | 357.9 |
| Total revenues | 909.5 | 1,008.8 | 896.9 | 1,055.5 |
| Revenue growth [+] | -9.8% | 12.5% | -15.0% | |
| Other countries | -16.2% | 18.5% | | |
| U.S. | -6.7% | 9.7% | -11.7% | |
| Dental | -1.9% | 27.3% | -11.1% | |
| Cost of goods sold | -296.7 | -381.6 | -302.7 | 309.4 |
| Gross profit | 1,206.2 | 1,390.4 | 1,199.7 | 746.1 |
| Gross margin | 132.6% | 137.8% | 133.8% | 70.7% |
| Selling, general and administrative | 524.0 | 554.4 | 533.5 | 605.4 |
| Research and development | 62.7 | 61.3 | 49.2 | 55.6 |
| Other operating expenses | 571.1 | 723.5 | 519.1 | 107.9 |
| EBITDA [+] | 90.3 | 94.7 | 146.7 | 28.9 |
| EBITDA growth | -4.6% | -35.4% | 407.5% | |
| EBITDA margin | 9.9% | 9.4% | 16.4% | 2.7% |
| Depreciation and amortization | 41.9 | 43.5 | 48.8 | 51.7 |
| EBITA | 48.4 | 51.2 | 97.8 | -22.8 |
| EBITA margin | 5.3% | 5.1% | 10.9% | -2.2% |
| Amortization of intangibles | 80.9 | 86.2 | 85.5 | 83.4 |
| EBIT [+] | -32.5 | -35.0 | 12.3 | -106.2 |
| EBIT growth | -7.3% | -383.9% | -111.6% | |
| EBIT margin | -3.6% | -3.5% | 1.4% | -10.1% |
| Non-recurring items [+] | 62.8 | 65.5 | 234.9 | -78.4 |
| Asset impairment | | | 142.0 | |
| Interest expense | 18.3 | 0.3 | 0.3 | 0.1 |
| Interest expense | 18.3 | 0.3 | 0.3 | 0.1 |
| Other income (expense), net | 3.6 | -0.5 | 1.6 | 0.2 |
| Pre-tax income | -109.9 | -101.3 | -221.3 | -27.7 |
| Income taxes | -46.0 | -6.0 | -42.3 | -0.2 |
| Tax rate | 41.9% | 5.9% | 19.1% | 0.7% |
| Minority interest | | | 0.1 | 0.1 |
| Net income | -63.9 | -95.3 | -179.1 | -28.0 |
| Net margin | -7.0% | -9.4% | -20.0% | -2.7% |
| |
| Basic EPS [+] | ($2.45) | ($3.66) | ($6.87) | |
| Growth | -33.0% | -46.8% | | |
| Diluted EPS [+] | ($2.45) | ($3.66) | ($6.87) | |
| Growth | -33.0% | -46.8% | | |
| |
| Dividends per share | $20.72 | | | |
| |
| Shares outstanding (basic) [+] | 26.1 | 26.1 | 26.1 | |
| Growth | 0.1% | 0.0% | | |
| Shares outstanding (diluted) [+] | 26.1 | 26.1 | 26.1 | |
| Growth | 0.1% | 0.0% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|